-
Innovation Ranking
Innovation Ranking – Element Solutions Inc
Element Solutions Inc (Element Solutions) is a diversified producer of high-technology specialty chemical products. The company's products include water-based hydraulic control fluids, surface and coating materials, photopolymers, and crop protection products which comprise fungicides, herbicides and insecticides. It offers its chemicals and processes to various industries which include agriculture, automotive, electronics, graphic arts, metals, plastic plating, animal health and offshore oil and gas production and drilling. Element Solutions also offers technical services. It markets its products under various brands including...
-
Company Insights
NewDecoding Procter & Gamble’s YouTube Advertisement Strategy in Q1 2024
The report on Procter & Gamble's advertising strategies on YouTube during the first quarter of 2024, focus on key products such as Fairy Maxx and Puffs Plus. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as Convenience, Efforless Cleaning, Comfort and Relief benefits. Moreover, the report examines the overarching themes of comfort, quality and sustainability infused into these campaigns. By synthesizing these insights, the report aims to provide a nuanced understanding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Dyslipidemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Dyslipidemia Drug Details: LY-3885125 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSHA-102 in Rett Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSHA-102 in Rett Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TSHA-102 in Rett Syndrome Drug Details: TSHA-102 (TGTX-104) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: LY-3885125...
-
Company Insights
NewDecoding Verizon’s YouTube Advertisement Strategy in Q1 2024​
The report on Verizon's advertising strategies on YouTube during the first quarter of 2024, focuses on key products such as Verizon Smart Family, Verizon Cloud and Verizon Internet Getaway. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as Signal Optimization, Enhanced Security and Easy Sharing. Moreover, the report examines the overarching themes of Innovation, Empowerment, Convenience, inclusivity and Community infused into these campaigns. By synthesizing these insights, the report aims to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Cervical Cancer Drug Details: MT-302 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Gastric Cancer Drug Details: MT-302 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MT-302 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MT-302 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MT-302 in Esophageal Cancer Drug Details: MT-302 is under development for...